Gastric Neoplasm Clinical Trial
Official title:
Randomized Phase III Trial of Surgery Plus Neoadjuvant TS-1 and Cisplatin Compared With Surgery Alone for Type 4 and Large Type 3 Gastric Cancer: Japan Clinical Oncology Group Study (JCOG 0501)
The aim of this study is to evaluate survival benefit of TS-1 plus cisplatin as a neoadjuvant chemotherapy in gastric cancer patient with resectable type 4 (linitis plastica type) and large type 3 tumor in comparison with surgery alone.
A randomized phase III study is going to started in Japan to compare TS-1 plus cisplatin as a neoadjuvant chemotherapy with surgery alone in patient with type 4 and large type 3 gastric cancer.A total of 300 patients will be accrued for this study from 35 institutions within five years. The primary endpoint is overall survival. The secondary endpoints are progression free survival (PFS), response rate, proportion of protocol achievement, proportion of curative resection, and adverse events. ;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02543411 -
Use of Lidocaine in Endoscopic Submucosal Dissection
|
N/A | |
| Completed |
NCT02128243 -
Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT00506207 -
A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal Malignancy
|
Phase 1 | |
| Completed |
NCT04830618 -
Aberrant DNA Methylation to Predict Metachronous Gastric Neoplasms
|
||
| Completed |
NCT02235246 -
The Effect of Perioperative Intravenous Magnesium on Pain After Endoscopic Submucosal Dissection for Gastric Neoplasm: Prospective Randomized Double-blind Placebo Controlled Study
|
Phase 4 | |
| Recruiting |
NCT04622098 -
Prevalence of Sub-epithelial Lesions Among Patients Undergoing EGDs in Egypt
|
||
| Terminated |
NCT01870791 -
Study of Additive Omega-3 Fish Oil to Palliative Chemotherapy to Treat Oesophagogastric Cancer
|
Phase 2 | |
| Completed |
NCT03255070 -
A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01)
|
Phase 1 | |
| Recruiting |
NCT06342427 -
Stomach Cancer Exosome-based Detection
|
||
| Recruiting |
NCT04780256 -
Endoscopic Resection of Gastrointestinal Neoplasms
|
||
| Recruiting |
NCT03065257 -
Endoscopic Resection Multicenter Registry
|
N/A | |
| Recruiting |
NCT05804331 -
The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
|
||
| Completed |
NCT05265221 -
Learning Curve for Gastric Endoscopic Submucosal Dissection
|
||
| Recruiting |
NCT03597581 -
A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer
|
Phase 1 | |
| Completed |
NCT00112099 -
GCSSG-SPNX: Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma: JCOG0110
|
Phase 3 | |
| Recruiting |
NCT04466631 -
Health and Employment After Gastro Intestinal Surgery - HEAGIS2
|
||
| Terminated |
NCT00149266 -
Randomized Controlled Trial to Evaluate Surgical Approaches to Gastric Cancer Invading the Esophagus (JCOG9502)
|
Phase 3 | |
| Completed |
NCT00149279 -
A Trial to Evaluate Para-aortic Lymphadenectomy for Gastric Cancer
|
Phase 3 | |
| Recruiting |
NCT06362070 -
Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Gastrectomy
|
N/A | |
| Completed |
NCT01824953 -
Long-term Follow-up Prognosis of Atrophic Gastritis After 3 Years
|
N/A |